Delivery Order SPE2DB22D2214-SPE2DB26FS2NG
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lamictal 100 mg tablets (quantity 100) with a ceiling value of $27,252.70. This is a firm fixed price delivery order with no set-aside designation, executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Lamictal XR 25 mg tablets (30-count units) with a ceiling value of $4,524.46 and a firm fixed price structure. The delivery order, which is scheduled for completion by April 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026)....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count units) under a firm fixed-price contract on July 2, 2025, with a ceiling value of $4,382.36 and an ultimate completion date of July 3, 2025. This award represents a non-competitive set-aside delivery order issued from AmerisourceBergen's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,702.10 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $5,644.62, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order represents a standard pharmaceutical procurement transaction sourced from AmerisourceBergen's extensive federal contract portfolio. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.58 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price delivery order issued without a set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a $8,951.56 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Lamictal XR 300 mg tablets, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $18,248.73 to supply Lamictal XR 50 mg tablets (30-count) with a firm fixed price structure and an ultimate completion date of March 26, 2025. This competitively awarded, non-set-aside contract was executed on March 25, 2025, with performance directed to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...